Product Information

PACERONE 100 MG TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.7762 per EA under NDC 00245014430. Its NADAC has been published 582 times since Nov 28, 2013.

FDA first approved this application on Apr 30, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PACERONE 100 MG TABLET

Amiodarone Hydrochloride
$0.7762per EA

Strength

100 mg/1

NDC

00245014430

Classification

Brand (ANDA)

Dosage Form

TABLET

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

AMIODARONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075135

FDA Approved

4/30/1998

TE Code

AB

On Market Since

11/15/2010

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for PACERONE 100 MG TABLET has been published 582 times since Nov 28, 2013, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7762 per EA
All-time high$3.7597 (Aug 13, 2014)
All-time low$0.7699 (Mar 19, 2025)
52-week high$0.8515
52-week low$0.7762
Median price$2.5016
Average price$2.0779
Largest weekly change-55.6% (Oct 13, 2021)
Weeks tracked582
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

-0.3%

6M

-0.5%

1Y

-8.8%

3Y

-32.5%

5Y

-70.0%

All

-69.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PACERONE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PACERONE 100 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.7762 per EA (NDC 00245014430), effective Aug 19, 2026.

How has the price of PACERONE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for PACERONE 100 MG TABLET has declined 69.4%. It has been tracked across 582 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PACERONE 100 MG TABLET?

Since Nov 28, 2013, the NADAC for PACERONE 100 MG TABLET has ranged from a low of $0.7699 (Mar 19, 2025) to a high of $3.7597 (Aug 13, 2014), with a median of $2.5016 per EA.

Are there cheaper alternatives to PACERONE 100 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMIODARONE HCL 100 MG TABLET, is $0.3864 per EA — about 50% below PACERONE 100 MG TABLET.

Who manufactures PACERONE 100 MG TABLET?

PACERONE 100 MG TABLET (NDC 00245014430) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.